The contract development and manufacturing organisation (CDMO) is selling the US and UK-based operations WuXi Advanced Therapies, including Oxford Genetics, to the investment group, but said its ...

The bill specifically mentioned contract development and manufacturing organisation (CDMO) WuXi AppTec, which makes a significant proportion of its revenues from US contracts, along with other ...

WuXi STA expects to hire about 500 people in the coming years to support Phase 1 of the manufacturing campus. A Chinese pharmaceutical company is moving forward with plans to build a massive $510 ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...

WuXi Biologics' CEO Chris Chen has denied that the company’s sale of its less than four-year-old Ireland site is due to the threat of the US Biosecure Act, and said that the number of new ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...